RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal clinical trial to use TETRANITE (R) to ...
Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 28, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, ...
Discover the leading AI code review tools reshaping DevOps practices in 2026, enhancing code quality, security, and team productivity with automated solutions.
The ADK operates alongside Ask Ascend, Apex’s established AI assistant launched in 2025. Together, they form the developer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results